Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 26, 2026

Robotic Duodenum-preserving Total Pancreatic Head Resection for Intraductal Papillary Mucinous Neoplasms
10:10

Robotic Duodenum-preserving Total Pancreatic Head Resection for Intraductal Papillary Mucinous Neoplasms

Published on: April 17, 2026

Pancreas Cancer Risk During Intraductal Papillary Mucinous Neoplasm Surveillance - A SEER-Based Comparison.

Ankur P Choubey1, Joanne F Chou2, Remo Alessandris1

  • 1Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.

Annals of Surgery
|May 25, 2026
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Investigating Age-Related Differences in Survival Outcomes and Mutation Status of Patients with Intrahepatic Cholangiocarcinoma.

Annals of surgical oncology·2026
Same author

Long-term Outcomes After Resection of Solitary Colorectal Liver Metastases.

Annals of surgical oncology·2026
Same author

ASO Visual Abstract: Long-Term Outcomes After Resection of Solitary Colorectal Liver Metastases.

Annals of surgical oncology·2026
Same author

Preferences for treatment for latent tuberculosis infection in primary care among people in the United States at increased risk of tuberculosis: a pilot survey.

medRxiv : the preprint server for health sciences·2026
Same author

ASO Visual Abstract: The Margin of the Largest Tumor Predicts Overall Survival After Resection of Multi-tumor Colorectal Liver Metastases.

Annals of surgical oncology·2026
Same author

ASO Visual Abstract: Eligibility for Liver Transplantation in Patients with Intrahepatic Cholangiocarcinoma.

Annals of surgical oncology·2026

Patients with intraductal papillary mucinous neoplasm (IPMN) have a significantly higher risk of developing pancreatic cancer (PDAC) than the general population. Risk varies by patient demographics and cyst characteristics, suggesting personalized surveillance strategies for PDAC detection.

Area of Science:

  • Gastroenterology
  • Oncology
  • Surgical Oncology

Background:

  • Intraductal papillary mucinous neoplasms (IPMN) are pre-malignant pancreatic cystic lesions requiring lifelong surveillance.
  • Despite surveillance, some patients develop pancreatic ductal adenocarcinoma (PDAC), while others show no cyst progression, leaving the true PDAC risk unclear.

Purpose of the Study:

  • To compare the incidence of pancreatic adenocarcinoma (PDAC) in patients undergoing surveillance for intraductal papillary mucinous neoplasm (IPMN).
  • To compare this incidence to a matched cohort from the Surveillance, Epidemiology, and End Results (SEER) database.

Main Methods:

  • Retrospective review of patients with IPMN under surveillance at a high-volume center.
  • Utilized an institutional cyst database including demographics, imaging features, and outcomes.
Keywords:
Cyst SurveillanceIPMNintraductal papillary mucinous neoplasmpancreatic adenocarcinoma

More Related Videos

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency
07:08

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Published on: February 2, 2024

Related Experiment Videos

Last Updated: May 26, 2026

Robotic Duodenum-preserving Total Pancreatic Head Resection for Intraductal Papillary Mucinous Neoplasms
10:10

Robotic Duodenum-preserving Total Pancreatic Head Resection for Intraductal Papillary Mucinous Neoplasms

Published on: April 17, 2026

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency
07:08

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Published on: February 2, 2024

  • Calculated standardized incidence ratio (SIR) for PDAC against an age- and year-matched SEER cohort.

    • Main Results:

    • Surveillance involved 1494 patients over 7,681 person-years; cumulative malignancy incidence at 60 months was 0.97%.
    • PDAC risk was 10-fold higher in the IPMN surveillance cohort compared to the general population (SIR: 10, CI: 7.2-15.6).
    • Highest risks observed with main pancreatic duct dilation ≥5 mm (SIR: 26.5) and BMI ≥30 (SIR: 20.6); lower risks seen with smaller IPMN or younger age.

    Conclusions:

    • The risk of malignancy in IPMN patients is substantially elevated compared to the general population.
    • Risk stratification based on demographics and cyst features (e.g., MPD dilation, BMI) is crucial.
    • Personalized surveillance may enhance early PDAC detection in high-risk individuals and reduce unnecessary imaging in low-risk groups.